Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 6 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Eye on Health: Cancer care programs offer support
22 WSBT South Bend· 15 hours agoBeacon Health System is offering patients advanced medical care and emotional support all in one place. Beacon has really designed its cancer care...
Bravo's Tabatha Coffey Reveals 25-Year Love Story and Tragic Death That Changed Her Life (Exclusive)
People Magazine· 16 hours ago"She taught me a lot in life and death," Coffey, 57, says now, looking back on her private love and...
Lung Cancer Drug’s 'Off-the-Charts’ Results Give Patients Hope
WebMD· 6 days agoAfter several tests, DeMara got the bombshell diagnosis: He had a rare lung cancer that typically affects nonsmokers, and at a much younger age than other ...
Texas man beats odds with cutting edge tech: Cancer free after stage 4 diagnosis
CBS Austin· 5 days agoEric Van Sciver, who was almost given the all-clear after battling colon cancer, discovered that his...
‘Unusual’ cancers emerged after the pandemic. Doctors ask if COVID is to blame.
Anchorage Daily News· 5 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Bravo Alum Tabatha Coffey Reveals Her Partner of 25 Years Died
E! News via Yahoo News· 13 hours agoTabatha Takes Over star Tabatha Coffey opened up for the first time about the 2022 death of her...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 2 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
Alan Kaufman tells his story at Zuckerberg Cancer Center's Cancer Survivors Day
Newsday· 3 days agoCity Marathon two dozen times, but then in 2017 he was diagnosed with Stage 4 metastatic melanoma....
Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion
Zacks via Yahoo Finance· 2 days agoRoche's (RHHBY) Alecensa gets the European Commission's approval as the first and only targeted...